ACADIA PHARMACEUTICALS INC shareholders Q3 2023

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRUIST FINANCIAL CORP 96,750$2,016,2700.00%
PUTNAM INVESTMENTS LLC 85,403$1,779,7990.00%
CREDIT SUISSE AG/ 149,342$3,112,2870.00%
Tower Research Capital LLC (TRC) 4,080$85,0270.00%
GOLDMAN SACHS GROUP INC 718,625$14,976,1450.00%
Bank of New York Mellon Corp 565,891$11,793,1660.00%
OSAIC HOLDINGS, INC. 100,306$2,090,2640.00%
Point72 Asset Management, L.P. 50,643$1,055,4000.00%
Ensign Peak Advisors, Inc 63,500$1,323,3400.00%
Nuveen Asset Management, LLC 451,302$9,405,1340.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 620,400$12,929,1360.00%
BARCLAYS PLC 217,270$4,5290.00%
VitalStone Financial, LLC 86$20.00%
GREAT WEST LIFE ASSURANCE CO /CAN/ 36,840$7670.00%
Lowe Wealth Advisors, LLC 180$3,7510.00%
NATIXIS ADVISORS, L.P. 34,763$7240.00%
SEI INVESTMENTS CO 52,191$1,087,6650.00%
JANE STREET GROUP, LLC 317,963$6,626,3490.00%
ProShare Advisors LLC 26,453$551,2810.00%
VICTORY CAPITAL MANAGEMENT INC 99,565$2,074,9350.00%
External links

This page lists ACADIA PHARMACEUTICALS INC's shareholders in Q3 2023. To view ACADIA PHARMACEUTICALS INC's shareholder history, click here.